The store will not work correctly when cookies are disabled.
N2-[(2-imidazol-1-ylphenyl)methyl]-N4,N4,5-trimethyl-pyrimidine-2,4-diamine
ID: ALA5087322
PubChem CID: 50983482
Max Phase: Preclinical
Molecular Formula: C17H20N6
Molecular Weight: 308.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cnc(NCc2ccccc2-n2ccnc2)nc1N(C)C
Standard InChI: InChI=1S/C17H20N6/c1-13-10-19-17(21-16(13)22(2)3)20-11-14-6-4-5-7-15(14)23-9-8-18-12-23/h4-10,12H,11H2,1-3H3,(H,19,20,21)
Standard InChI Key: KVEOZGZPAVUHBK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-3.2145 0.2901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5000 0.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7881 0.2905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7881 -0.5347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4982 -0.9465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2145 -0.5384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0734 0.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3589 0.2905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3557 0.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3560 1.5283 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0688 1.9390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7837 1.5262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7852 0.7051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0734 0.2887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4983 1.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4999 0.2926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2145 0.7051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4999 -0.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0734 -0.9472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3200 -0.6118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2319 -1.2247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1805 -1.9390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9872 -1.7675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
7 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
12 15 1 0
13 16 1 0
16 17 1 0
16 18 1 0
19 4 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.39 | Molecular Weight (Monoisotopic): 308.1749 | AlogP: 2.65 | #Rotatable Bonds: 5 |
Polar Surface Area: 58.87 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.99 | CX LogP: 2.90 | CX LogD: 2.74 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.79 | Np Likeness Score: -2.04 |
References
1. Levit Kaplan A, Strachan RT, Braz JM, Craik V, Slocum S, Mangano T, Amabo V, O'Donnell H, Lak P, Basbaum AI, Roth BL, Shoichet BK.. (2022) Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor., 65 (5.0): [PMID:35195401] [10.1021/acs.jmedchem.1c02031] |